MIKEL
GARCÍA PUGA
Hospital Universitario de Donostia
San Sebastián, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (8)
2022
-
Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity
Cancer Research, Vol. 82, Núm. 7, pp. 1283-1297
-
Senescence plays a role in myotonic dystrophy type 1
JCI insight, Vol. 7, Núm. 19
-
Targeting Myotonic Dystrophy Type 1 with Metformin
International Journal of Molecular Sciences, Vol. 23, Núm. 5
2020
-
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 1, pp. 126-131
-
Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin
Aging, Vol. 12, Núm. 7, pp. 6260-6275
-
SOX9 promotes tumor progression through the axis BMI1-p21CIP
Scientific Reports, Vol. 10, Núm. 1
2016
-
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation
Neurology, Vol. 87, Núm. 12, pp. 1250-1257
2015
-
Muscle wasting in myotonic dystrophies: A model of premature aging
Frontiers in Aging Neuroscience, Vol. 7, Núm. JUN